NOD2 mosaicism in Blau syndrome

被引：0

作者：

Mensa-Vilaro A. ^{[1
]}

De Inocencio J. ^{[2
]}

Cham W.T. ^{[3
]}

Gonzalez-Roca E. ^{[1
]}

Tejada-Palacios P. ^{[2
]}

Tang S.P. ^{[3
]}

Ruiz-Ortiz E. ^{[1
]}

Enriquez-Merayo E. ^{[2
]}

Lim S.C. ^{[3
]}

Magri G. ^{[4
]}

Plaza S. ^{[1
]}

Anton M.C. ^{[1
]}

Cerutti A. ^{[4
]}

Ariffin R. ^{[5
]}

Yagüe J. ^{[1
]}

Arostegui J.I. ^{[1
]}

机构：

[1] Hospital Clínic, Immunology, Barcelona

[2] Hospital 12 de Octubre, Pediatric Rheumatology, Madrid

[3] Selayang Hospital, Kuala Lumpur

[4] Institut Municipal d'Investigació Mèdica, Barcelona

[5] Kuala Lumpur Hospital, Kuala Lumpur

来源：

Pediatric Rheumatology | / 13卷 / Suppl 1期

关键词：

Uveitis; Sanger Sequencing; Autoinflammatory Disease; NOD2 Mutation; Erythematous Rash;

D O I：

10.1186/1546-0096-13-S1-P59

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

共 50 条

[1] Somatic NOD2 mosaicism in Blau syndrome
不详
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (02) : 484 - +
[2] First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism
Mensa-Vilaro, Anna
Cham, Weng Tarng
Tang, Swee Ping
Lim, Sern Chin
Gonzalez-Roca, Eva
Ruiz-Ortiz, Estibaliz
Ariffin, Roziana
Yaguee, Jordi
Arostegui, Juan I.
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (04) : 1039 - 1044
[3] Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function
Mao, Liming
Dhar, Atika
Meng, Guangxun
Fuss, Ivan
Montgomery-Recht, Kim
Yang, Zhiqiong
Xu, Qiuyun
Kitani, Atsushi
Strober, Warren
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4] T cell intrinsic role for NOD2 in Blau Syndrome
Napier, Ruth J.
Vance, Emily E.
Koney, Kylie V.
Lee, Ellen J.
Davey, Michael M.
Rosenzweig, Holly L.
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[5] Blau Syndrome-Associated Uveitis and the NOD2 Gene
Pillai, Parvathy
Sobrin, Lucia
SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 327 - 332
[6] Blau syndrome associated with a CARD15/NOD2 mutation
Snyers, Bernadette
Dahan, Karin
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (06) : 1089 - 1092
[7] Blau syndrome with a rare mutation in exon 9 of NOD2 gene
Velickovic, Jelena
Silan, Fatma
Bir, Firdevs Dincsoy
Silan, Coskun
Albuz, Burcu
Ozdemir, Ozturk
AUTOIMMUNITY, 2019, 52 (7-8) : 256 - 263
[8] A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome
Rodrigues, Filipa G.
Petrushkin, Harry
Webster, Andrew R.
Bickerstaff, Maria
Moraitis, Elena
Rowczenio, Dorota
Arostegui, Juan, I
Westcott, Mark
OPHTHALMIC GENETICS, 2021, 42 (06) : 753 - 764
[9] Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
Ueki, Yoko
Takimoto-Ito, Riko
Saito, Megumu K. K.
Tanizaki, Hideaki
Kambe, Naotomo
FRONTIERS IN IMMUNOLOGY, 2023, 14
[10] A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome
Jain, Lubhani
Gupta, Namrata
Reddy, Mamatha M.
Mittal, Ruchi
Barik, Manas Ranjan
Panigrahi, Bharat
Monie, Tom
Basu, Soumyava
OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (02) : 292 - 294

← 1 2 3 4 5 →